Literature DB >> 21211588

CD8+ T cell immunity to 2009 pandemic and seasonal H1N1 influenza viruses.

Kristin Scheible1, Gang Zhang, Jane Baer, Mitra Azadniv, Kris Lambert, Gloria Pryhuber, John J Treanor, David J Topham.   

Abstract

A novel strain of H1N1 influenza A virus (pH1N1) emerged in 2009, causing a worldwide pandemic. Several studies suggest that this virus is antigenically more closely related to human influenza viruses that circulated prior to 1957 than viruses of more recent seasonal influenza varieties. The extent to which individuals who are naïve to the 2009 pH1N1 virus carry cross-reactive CD8+ T cells is not known, but a certain degree of reactivity would be expected since there is substantial conservation among the internal proteins of the virus. In the present study, we examined the production of multiple cytokines in response to virus from CD8+ T cells in healthy adult subjects, between 18 and 50 years of age (born post 1957), who had no evidence of exposure to the 2009 pH1N1 virus, and had blood collected prior to the emergence of the pandemic in April of 2009. Human peripheral blood mononuclear cells (PBMCs) were stimulated in vitro with a panel of live viruses, and assayed by intracellular cytokine staining and flow cytometry. Although results were variable, most subjects exhibited cytokine positive CD8+ T cells in response to pH1N1. Cytokine producing cells were predominantly single positive (IL2, IFNγ, or TNFα); triple-cytokine producing cells were relatively rare. This result suggests that although many adults carry cross-reactive T cells against the emergent pandemic virus, these cells are in a functionally limited state, possibly because these subjects have not had recent exposure to either seasonal or pandemic influenza strains.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21211588      PMCID: PMC3061835          DOI: 10.1016/j.vaccine.2010.12.073

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  55 in total

1.  A randomized, double blind study in young healthy adults comparing cell mediated and humoral immune responses induced by influenza ISCOM vaccines and conventional vaccines.

Authors:  G F Rimmelzwaan; N Nieuwkoop; A Brandenburg; G Sutter; W E Beyer; D Maher; J Bates; A D Osterhaus
Journal:  Vaccine       Date:  2000-12-08       Impact factor: 3.641

2.  Cross-reactive antibody responses to the 2009 A/H1N1v influenza virus in the Italian population in the pre-pandemic period.

Authors:  Caterina Rizzo; Maria Cristina Rota; Antonino Bella; Valeria Alfonsi; Silvia Declich; Maria Grazia Caporali; Alessia Ranghiasci; Giulia Lapini; Simona Piccirella; Stefania Salmaso; Emanuele Montomoli
Journal:  Vaccine       Date:  2010-03-20       Impact factor: 3.641

3.  Clinical and immunologic predictors of influenza illness among vaccinated older adults.

Authors:  Zainab Shahid; Alison Kleppinger; Beth Gentleman; Ann R Falsey; Janet E McElhaney
Journal:  Vaccine       Date:  2010-07-31       Impact factor: 3.641

4.  Prior H1N1 influenza infection and susceptibility of Cleveland Family Study participants during the H2N2 pandemic of 1957: an experiment of nature.

Authors:  Suzanne L Epstein
Journal:  J Infect Dis       Date:  2005-11-21       Impact factor: 5.226

5.  Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major.

Authors:  Patricia A Darrah; Dipti T Patel; Paula M De Luca; Ross W B Lindsay; Dylan F Davey; Barbara J Flynn; Søren T Hoff; Peter Andersen; Steven G Reed; Sheldon L Morris; Mario Roederer; Robert A Seder
Journal:  Nat Med       Date:  2007-06-10       Impact factor: 53.440

6.  Tecumseh study of illness. XIII. Influenza infection and disease, 1976-1981.

Authors:  A S Monto; J S Koopman; I M Longini
Journal:  Am J Epidemiol       Date:  1985-06       Impact factor: 4.897

7.  Primary influenza A virus infection induces cross-protective immunity against a lethal infection with a heterosubtypic virus strain in mice.

Authors:  J H C M Kreijtz; R Bodewes; G van Amerongen; T Kuiken; R A M Fouchier; A D M E Osterhaus; G F Rimmelzwaan
Journal:  Vaccine       Date:  2006-09-07       Impact factor: 3.641

Review 8.  Heterosubtypic immunity to influenza A virus: where do we stand?

Authors:  Kristie M Grebe; Jonathan W Yewdell; Jack R Bennink
Journal:  Microbes Infect       Date:  2008-07-09       Impact factor: 2.700

9.  Cross-recognition of avian H5N1 influenza virus by human cytotoxic T-lymphocyte populations directed to human influenza A virus.

Authors:  J H C M Kreijtz; G de Mutsert; C A van Baalen; R A M Fouchier; A D M E Osterhaus; G F Rimmelzwaan
Journal:  J Virol       Date:  2008-03-19       Impact factor: 5.103

10.  Measurement of hemagglutination-inhibiting antibody to influenza virus in the 1976 influenza vaccine program: methods and test reproducibility.

Authors:  G R Noble; H S Kaye; W B Yarbrough; B K Fiedler; C J Reed; M B Felker; A P Kendal; W R Dowdle
Journal:  J Infect Dis       Date:  1977-12       Impact factor: 5.226

View more
  22 in total

Review 1.  Influenza, immune system, and pregnancy.

Authors:  Renju S Raj; Elizabeth A Bonney; Mark Phillippe
Journal:  Reprod Sci       Date:  2014-06-04       Impact factor: 3.060

2.  Cellular immune correlates of protection against symptomatic pandemic influenza.

Authors:  Saranya Sridhar; Shaima Begom; Alison Bermingham; Katja Hoschler; Walt Adamson; William Carman; Thomas Bean; Wendy Barclay; Jonathan J Deeks; Ajit Lalvani
Journal:  Nat Med       Date:  2013-09-22       Impact factor: 53.440

3.  Cross-allele cytotoxic T lymphocyte responses against 2009 pandemic H1N1 influenza A virus among HLA-A24 and HLA-A3 supertype-positive individuals.

Authors:  Jun Liu; Shihong Zhang; Shuguang Tan; Yong Yi; Bin Wu; Bin Cao; Fengcai Zhu; Chen Wang; Hua Wang; Jianxun Qi; George F Gao
Journal:  J Virol       Date:  2012-09-26       Impact factor: 5.103

4.  Infection with seasonal influenza virus elicits CD4 T cells specific for genetically conserved epitopes that can be rapidly mobilized for protective immunity to pandemic H1N1 influenza virus.

Authors:  Shabnam Alam; Andrea J Sant
Journal:  J Virol       Date:  2011-10-05       Impact factor: 5.103

5.  Memory CD8+ T cells are sufficient to alleviate impaired host resistance to influenza A virus infection caused by neonatal oxygen supplementation.

Authors:  Matthew Giannandrea; Min Yee; Michael A O'Reilly; B Paige Lawrence
Journal:  Clin Vaccine Immunol       Date:  2012-07-11

Review 6.  Two years after pandemic influenza A/2009/H1N1: what have we learned?

Authors:  Vincent C C Cheng; Kelvin K W To; Herman Tse; Ivan F N Hung; Kwok-Yung Yuen
Journal:  Clin Microbiol Rev       Date:  2012-04       Impact factor: 26.132

7.  Antibody-dependent cellular cytotoxicity is associated with control of pandemic H1N1 influenza virus infection of macaques.

Authors:  Sinthujan Jegaskanda; Jason T Weinfurter; Thomas C Friedrich; Stephen J Kent
Journal:  J Virol       Date:  2013-03-06       Impact factor: 5.103

8.  Predominance of heterosubtypic IFN-γ-only-secreting effector memory T cells in pandemic H1N1 naive adults.

Authors:  Saranya Sridhar; Shaima Begom; Alison Bermingham; Thedi Ziegler; Kim L Roberts; Wendy S Barclay; Peter Openshaw; Ajit Lalvani
Journal:  Eur J Immunol       Date:  2012-08-15       Impact factor: 5.532

Review 9.  The human side of influenza.

Authors:  Christine M Oshansky; Paul G Thomas
Journal:  J Leukoc Biol       Date:  2012-02-23       Impact factor: 4.962

10.  Influenza A/H1N1 septic shock in a patient with systemic lupus erythematosus. A case report.

Authors:  Konstantinos Tselios; Ritsa Tsioka; Alexandros Sarantopoulos; Eleni Mouloudi; Panagiota Boura
Journal:  BMC Infect Dis       Date:  2011-12-29       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.